Eicosapentaenoic acid enhances the effects of mesenchymal Stromal cell therapy in experimental allergic asthma

Frontiers in Immunology

Volumn 9, Issue MAY, 2018, Pages

  Abreu, Soraia Carvalho ^a,b   Lopes Pacheco, Miquéias ^a   Silva, Adriana Lopes da ^a   Xisto, Debora Gonçalves ^a   Oliveira, Tainá Batista de ^a   Kitoko, Jamil Zola ^a   Castro, Lígia Lins de ^a   Amorim, Natália Recardo ^a   Martins, Vanessa ^a   Silva, Luisa H A ^a   Gonçalves de Albuquerque, Cassiano Felippe ^c,d   Faria Neto, Hugo Caire de Castro ^d   Olsen, Priscilla Christina ^a   Weiss, Daniel Jay ^b   Morales, Marcelo Marcos ^a,e   Diaz, Bruno Lourenço ^a   Rocco, Patricia Rieken Macêdo ^a,e  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e National Institute of Science and Technology for Gene Therapy   (Brazil)

Author keywords

Histology; Inflammation; Lung mechanics; Remodeling; Resolvin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; FAT DROPLET; HOUSE DUST MITE ALLERGEN EXTRACT; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; PROSTAGLANDIN E2; RESOLVIN D1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

AIRWAY REMODELING; ALLERGIC ASTHMA; ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTION; CELL COUNT; CELL THERAPY; COLLAGEN FIBER; COLLAPSE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG MECHANICS; LYMPH NODE; MACROPHAGE; MALE; MESENCHYMAL STROMA CELL; MESENCHYMAL STROMAL CELL THERAPY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE BLIND PROCEDURE; THERAPY EFFECT; THYMUS; Y CHROMOSOME;

EID: 85047470450     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.01147     Document Type: Article

References (58)

1. Fahy JV. Type 2 inflammation in asthma - present in most, absent in many. Nat Rev Immunol (2015) 15:57-65. doi:10.1038/nri3807
2. Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol (2011) 128:451-62. doi:10.1016/j.jaci.2011.04.047
3. Royce SG, Tang ML. The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention. Curr Mol Pharmacol (2009) 2:169-81. doi:10.2174/1874467210902020169
4. Barnes PJ. New therapies for asthma: is there any progress? Trends Pharmacol Sci (2010) 31:335-43. doi:10.1016/j.tips.2010.04.009
5. Papierniak ES, Lowenthal DT, Harman E. Novel therapies in asthma: leukotriene antagonists, biologic agents, and beyond. Am J Ther (2013) 20:79-103. doi:10.1097/MJT.0b013e31826915c2
6. Cruz FF, Borg ZD, Goodwin M, Sokocevic D, Wagner DE, Coffey A, et al. Systemic administration of human bone marrow-derived mesenchymal stromal cell extracellular vesicles ameliorates Aspergillus hyphal extract-induced allergic airway inflammation in immunocompetent mice. Stem Cells Transl Med (2015) 4:1302-16. doi:10.5966/sctm.2014-0280
7. Abreu SC, Antunes MA, Xisto DG, Cruz FF, Branco VC, Bandeira E, et al. Bone marrow, adipose, and lung tissue-derived murine mesenchymal stromal cells release different mediators and differentially affect airway and lung parenchyma in experimental asthma. Stem Cells Transl Med (2017) 6:1557-67. doi:10.1002/sctm.16-0398
8. Silva JD, Lopes-Pacheco M, Paz AHR, Cruz FF, Melo EBM, Oliveira MV, et al. Mesenchymal stem cells from bone marrow, adipose, and lung tissues differentially mitigate lung and distal organ damage in experimental acute respiratory distress syndrome. Crit Care Med (2018) 46:e132-40. doi:10.1097/CCM.0000000000002833
9. Nemeth K, Keane-Myers A, Brown JM, Metcalfe DD, Gorham JD, Bondoc VG, et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci U S A (2010) 17:5652-7. doi:10.1073/pnas.0910720107
10. Goodwin M, Sueblinvong V, Eisenhauer P, Ziats NP, LeClair L, Poynter ME, et al. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells (2011) 29:1137-48. doi:10.1002/stem.656
11. Mathias LJ, Khong SM, Spyroglou L, Payne NL, Siatskas C, Thorburn AN, et al. Alveolar macrophages are critical for the inhibition of allergic asthma by mesenchymal stromal cells. J Immunol (2013) 191:5914-24. doi:10.4049/jimmunol.1300667
12. Marinas-Pardo L, Mirones I, Amor-Carro O, Fraga-Iriso R, Lema-Costa B, Cubillo I, et al. Mesenchymal stem cells regulate airway contractile tissue remodeling in murine experimental asthma. Allergy (2014) 69:730-40. doi:10.1111/all.12392
13. Kitoko JZ, Nascimento AP, Abreu SC, Cruz FF, Arantes AC, Xisto DG, et al. Therapeutic administration of bone marrow-derived mesenchymal stromal cells reduces airway inflammation without upregulating Tregs in experimental asthma. Clin Exp Allergy (2018) 48:205-16. doi:10.1111/cea.13048
14. Gharibi B, Cama G, Capurro M, Thompson I, Deb S, Di Silvio L, et al. Gene expression responses to mechanical stimulation of mesenchymal stem cells seeded on calcium phosphate cement. Tissue Eng Part A (2013) 19:2426-38. doi:10.1089/ten.tea.2012.0623
15. de Witte SF, Franquesa M, Baan CC, Hogduijn MJ. Toward development of iMesenchymal stem cells for immunomodulatory therapy. Front Immunol (2016) 6:648. doi:10.3389/fimmu.2015.00648
16. Lan YW, Choo KB, Chen CM, Hung TH, Chen YB, Hsieh CH, et al. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis. Stem Cell Res Ther (2015) 6:97. doi:10.1186/s13287-015-0081-6
17. Feng Y, Luo S, Yang P, Song Z. Electric pulse current stimulation increases electrophysiological properties of If current reconstructed in mHCN4-transfected canine mesenchymal stem cells. Exp Ther Med (2016) 11:1323-9. doi:10.3892/etm.2016.3072
18. Yates CM, Calder PC, Ed Rainger G. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol Ther (2014) 141:272-82. doi:10.1016/j.pharmthera.2013.10.010
19. Freitas HR, Isaac AR, Malcher-Lopes R, Diaz BL, Trevenzoli IH, De Melo Reis RA. Polyunsaturated fatty acids and endocannabinoids in health and disease. Nutr Neurosci (2017) 7:1-20. doi:10.1080/1028415X.2017.1347373
20. Mickleborough TD, Tecklenburg SL, Montgomery GS, Lindley MR. Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. Clin Nutr (2009) 28:71-7. doi:10.1016/j.clnu.2008.10.012
21. Khaddaj-Mallat R, Morin C, Rousseau E. Novel n-3 PUFA monoacylglycerides of pharmacological and medicinal interest: anti-inflammatory and anti-proliferative effects. Eur J Pharmacol (2016) 792:70-7. doi:10.1016/j.ejphar.2016.10.038
22. Bargut TC, Ferreira TP, Daleprane JB, Martins MA, Silva PM, Aguila MB. Fish oil has beneficial effects on allergen-induced airway inflammation and hyperreactivity in mice. PLoS One (2013) 8:e75059. doi:10.1371/journal.pone.0075059
23. Olsen PC, Kitoko JZ, Ferreira TP, de-Azevedo CT, Arantes AC, Martins MA. Glucocorticoids decrease Treg cell numbers in lungs of allergic mice. Eur J Pharmacol (2015) 747:52-8. doi:10.1016/j.ejphar.2014.11.034
24. Antunes MA, Abreu SC, Cruz FF, Teixeira AC, Lopes-Pacheco M, Bandeira E, et al. Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respir Res (2014) 15:118. doi:10.1186/s12931-014-0118-x
25. Burburan SM, Xisto DG, Ferreira HC, Riva Ddos R, Carvalho GM, Zin WA, et al. Lung mechanics and histology during sevoflurane anesthesia in a model of chronic allergic asthma. Anesth Analg (2007) 104:631-7. doi:10.1213/01.ane.0000255073.96001.cb
26. Bates JH, Ludwig MS, Sly PD, Brown K, Martin JG, Fredberg JJ. Interrupter resistance elucidated by alveolar pressure measurement in open-chest normal dogs. J Appl Physiol (1988) 65:408-14. doi:10.1152/jappl.1988.65.1.408
27. Xisto DG, Farias LL, Ferreira HC, Picanço MR, Amitrano D, Lapa E, et al. Lung parenchyma remodeling in a murine model chronic allergic inflammation. Am J Respir Crit Care Med (2005) 171:829-37. doi:10.1164/rccm.200408-997OC
28. Rocco PR, Negri EM, Kurtz PM, Vasconcellos FP, Silva GH, Capelozzi VL, et al. Lung tissue mechanics and extracellular matrix remodeling in acute lung injury. Am J Respir Crit Care Med (2001) 164:1061-71. doi:10.1164/ajrccm.164.6.2007062
29. da Silva AL, Magalhães RF, Branco VC, Silva JD, Cruz FF, Marques PS, et al. The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma. Br J Pharmacol (2016) 172:1236-47. doi:10.1111/bph.13430
30. Lopes-Pacheco M, Xisto DG, Ornellas FM, Antunes MA, Abreu SC, Rocco PR, et al. Repeated administration of bone marrow-derived cells prevents disease progression in experimental silicosis. Cell Physiol Biochem (2013) 32:1681-94. doi:10.1159/000356603
31. Bozza PT, Payne JL, Morham SG, Langenbach R, Smithies O, Weller PF. Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. Proc Natl Acad Sci U S A (1996) 93:11091-6. doi:10.1073/pnas.93.20.11091
32. Maron-Gutierrez T, Castiglione RC, Xisto DG, Oliveira MG, Cruz FF, Peçanha R, et al. Bone marrow-derived mononuclear cells therapy attenuates silica-induced lung fibrosis. Eur Respir J (2011) 37:1217-25. doi:10.1183/09031936.00205009
33. Bozza PT, Melo RC, Bandeira-Melo C. Leukocyte lipid bodies regulation and function: contribution to allergy and host defense. Pharmacol Ther (2007) 113:30-49. doi:10.1016/j.pharmthera.2006.06.006
34. Nials AT, Uddin S. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis Model Mech (2008) 1:213-20. doi:10.1242/dmm.000323
35. Gregory LG, Lloyd CM. Orchestrating house dust mite-associated allergy in the lung. Trends Immunol (2011) 32:402-11. doi:10.1016/j.it.2011.06.006
36. Kavanagh H, Mahon BP. Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy (2011) 66:523-31. doi:10.1111/j.1398-9995.2010.02509.x
37. Lathrop MJ, Bonenfant NR, Sokocevic D, Borg ZD, Goodwin M, Loi R, et al. Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th19 signaling pathway. Stem Cells Transl Med (2014) 3:194-205. doi:10.5966/sctm.2013-0061
38. Duong KM, Arikkatt J, Ullah MA, Lynch JP, Zhang V, Atkinson K, et al. Immunomodulation of airway epithelium cell activation by mesenchymal stromal cells ameliorates house dust mite-induced airway inflammation in mice. Am J Respir Cell Mol Biol (2015) 53:615-24. doi:10.1165/rcmb.2014-0431OC
39. Urbanek K, De Angelis A, Spaziano G, Piegari E, Matteis M, Cappetta D, et al. Intratracheal administration of mesenchymal stem cells modulates tachykinin system, suppresses airway remodeling and reduces airway hyperresponsiveness in an animal model. PLoS One (2016) 11:e0158746. doi:10.1371/journal.pone.0158746
40. Zhao S, Wehner R, Bornhauser M, Wassmuth R, Bachmann M, Schmitz M. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev (2010) 19:607-14. doi:10.1089/scd.2009.0345
41. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol (2008) 8:349-61. doi:10.1038/nri2294
42. Tull SP, Yates CM, Maskrey BH, O'Donnell VB, Madden J, Grimble RF, et al. Omega-3 fatty acids and inflammation: novel interactions reveal a new step in neutrophil recruitment. PLoS Biol (2009) 7:e1000177. doi:10.1371/journal.pbio.1000177
43. Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients (2010) 2:355-74. doi:10.3390/nu2030355
44. Moreira LS, Piva B, Gentile LB, Mesquita-Santos FP, D'Avila H, Maya-Monteiro CM, et al. Cytosolic phospholipase A2-driven PGE2 synthesis within unsaturated fatty acids-induced lipid bodies of epithelial cells. Biochim Biophys Acta (2009) 1791:156-65. doi:10.1016/j.bbalip.2009.01.003
45. Koltsida O, Karamnov S, Pyrillou K, Vickery T, Chairakaki AD, Tamvakopoulos C, et al. Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. EMBO Mol Med (2013) 5:762-75. doi:10.1002/emmm.201201891
46. Birrell MA, Maher SA, Dekkak B, Jones V, Wong S, Brook P, et al. Anti-inflammatory effects of PGE2 in lung: role of the EP4 receptor subtype. Thorax (2015) 70:740-7. doi:10.1136/thoraxjnl-2014-206592
47. van Scott MR, Justice JP, Bradfield JF, Enright E, Sigounas A, Sur S. IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. Am J Physiol Lung Cell Mol Physiol (2000) 278:L667-74. doi:10.1152/ajplung.2000.278.4.L667
48. Vasandan AB, Jahnavi S, Shashank C, Prasad P, Kumar A, Prasanna SJ. Human mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE2-dependent mechanism. Sci Rep (2016) 6:38308. doi:10.1038/srep38308
49. Carvalho SC, Apolinario LM, Matheus SM, Santo Neto H, Marques MJ. EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype. J Neuroimmunology (2013) 264:41-7. doi:10.1016/j.jneuroim.2013.09.007
50. Takamura M, Kurokawa K, Ootsuji H, Inoue O, Okada H, Nomura A, et al. Long-term administration of eicosapentaenoic acid improves post-myocardial infarction cardiac remodeling in mice by regulating macrophage polarization. J Am Heart Assoc (2017) 6:e004560. doi:10.1161/JAHA.116.004560
51. Lee R, Pulin A, Seo M, Kota D, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell (2009) 5:54-63. doi:10.1016/j.stem.2009.05.003
52. Mei SH, Haitsma JJ, Dos Santos CC, Deng Y, Lai PF, Slutsky AS, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med (2010) 182:1047-57. doi:10.1164/rccm.201001-0010OC
53. Borowski A, Kuepper M, Horn U, Knüpfer U, Zissel F, Höhne K, et al. Interleukin-13 acts as an apoptotic effector on lung epithelial cells and induces pro-fibrotic gene expression in lung fibroblasts. Clin Exp Allergy (2008) 38:619-28. doi:10.1111/j.1365-2222.2008.02944.x
54. Bellini A, Marini MA, Bianchetti L, Barczyk M, Schmidt M, Mattoli S. Interleukin (IL)-4, IL-13 and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal Immunol (2012) 5:140-9. doi:10.1038/mi.2011.60
55. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med (2004) 10:1095-103. doi:10.1038/nm1105
56. Penke LRK, Huang SK, White ES, Peters-Golden M. Prostaglandin E2 inhibits a-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-A. J Biol Chem (2014) 289:17151-62. doi:10.1074/jbc. M114.558130
57. Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med (2002) 8:885. doi:10.1038/nm734
58. Rogerio AP, Haworth O, Croze R, Oh SF, Uddin M, Carlo T, et al. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol (2012) 189:1983-91. doi:10.4049/jimmunol.1101665